Clinical Trials on Esophageal Cancer in Germany

Total 2503 results

Prof. Wolfgang Janni
Roche Pharma AG; Novartis Pharmaceuticals; Celgene Corporation; Eisai GmbH

Active, not recruiting

Detect V / CHEVENDO (Chemo vs. Endo)

Metastatic Breast Cancer

Germany
University Hospital Tuebingen
Paul Ehrlich Institute, Langen, Germany

Completed

Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line (KS2422) (KS2422-vacc)

Metastatic Breast Cancer

Germany
German Breast Group

Completed

Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer (AMICA)

Breast Cancer Metastatic

Germany
University of Jena

Completed

Analysis of Circulating Epithelial Tumor Cells in Peripheral Blood in Patients With Primary Non-metastatic Breast Cancer Under Adjuvant Radiotherapy

Breast Cancer Female

Germany
iOMEDICO AG
Roche Pharma AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis...

Completed

Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer (CARIN)

Metastatic Breast Cancer

Germany
Novartis

Completed

Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy

Metastatic Breast Cancer

Germany
German Breast Group
Boehringer Ingelheim

Completed

Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy (DAFNE)

Unilateral HER2 Positive Breast Cancer

Germany
AstraZeneca

Completed

ASTERIX: Low Dose ASA and Nexium

Gastroesophageal Reflux

Bulgaria, Italy, South Africa, Spain, Hungary, Canada, Hong Kong, Greece, Germany, Australia, United Kingdom
University Hospital, Essen

Recruiting

Empower the Heart of Patients With Terminal Cancer Using Cardiac Medicines Trial (EMPATICC)

Pre-terminal Cancer

Germany
Merck Sharp & Dohme LLC

Completed

First-line Esophageal Carcinoma Study With Pembrolizumab Plus Chemo vs. Chemo (MK-3475-590/KEYNOTE-590)

Esophageal Neoplasms

Taiwan, China, United States, Argentina, Australia, Brazil, Canada, Chile, Colombia, Costa Rica, Denmark, France, Germany, Guatemala, Hong Kong, Japan, Korea, Republic of, Malaysia, Peru, Romania, Russian Federation, South Africa, S... and more
German Breast Group
GlaxoSmithKline; Stemline Therapeutics, Inc.

Not yet recruiting

Evaluating the Addition of Elacestrant (Oral SERD) to Niraparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer (ELEMENT)

BRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | Hormone Receptor Positive HER-2 Negative Breast Cancer | Advanced or Metastatic Breast Cancer

Germany
Kliniken Essen-Mitte

Recruiting

TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes (SenTa2)

Breast Cancer | Node-positive Breast Cancer

Germany
RWTH Aachen University
Univ.-Prof. Dr. med. F. Kiessling

Unknown

KVUS at Neoadjuvant CTx of Breast Cancer

Early Primary Breast Cancer

Germany
Johannes Gutenberg University Mainz

Completed

Optimal Surgery and MRI Based Radiochemotherapy in Rectal Carcinoma (OCUM)

Rectal Cancer Stage II | Rectal Cancer Stage III

Germany
West German Study Group
Sanofi; Amgen

Completed

Anthracycline-free Taxane Based Chemotherapy in Patients With HER2/Neu Negative Early Breast Cancer (planB)

Primary Breast Cancer | Her2 Non-overexpressing

Germany
University of Witten/Herdecke
Heidehof Foundation Stuttgart; Community Hospital Herdecke; Nordoff/Robbins Music... and other collaborators

Recruiting

Music Therapy With Cancer Affected Children and Their Families (INMUT)

Pediatric Cancer

Germany
University Hospital Heidelberg
Health Economics and Health Care Management, Bielefeld University; Chair of... and other collaborators

Completed

Financial Effects of a Tumor Disease - Development and Validation of a Patient Reported Outcome Measure in Germany (FIAT)

Cancer

Germany
Krankenhaus Nordwest

Completed

A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy (AIO-STO-0111)

Advanced Gastric Cancer | Esophagogastric Junction Cancer

Germany
Heidelberg University
Dafra Pharma; Hector-Stiftung; Monika-Kutzner Stiftung, Berlin, Germany; HEIFAN-Heidelberger...

Completed

Study of Artesunate in Metastatic Breast Cancer (ARTIC-M33/2)

Metastatic Breast Cancer | Locally Advanced Breast Cancer

Germany
Cankado GmbH

Recruiting

One Million Cancer Treatment Months (OMCAT)

Cancer

Germany
University Hospital Heidelberg

Recruiting

Carbon Ion Re-Radiotherapy in Patients With Recurrent or Progressive Locally Advanced Head-and-Neck Cancer (CARE)

Locally Advanced Head-and-Neck Cancer

Germany
Bayer
Janssen Research & Development, LLC

Completed

An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism) (H2H-OSCAR-US)

Cancer | Venous Thromboembolism | Treatment of Venous Thromboembolism in Cancer Patients

Germany
University of Leipzig
Universitätsklinikum Hamburg-Eppendorf

Recruiting

Peer2Me: A Peer Supported Program for Adolescent and Young Adult Cancer Patients (Peer2Me)

Cancer | Psychosocial Problem

Germany
German Cancer Research Center
University Hospital Heidelberg; National Center for Tumor Diseases, Heidelberg

Completed

Effects of a Supervised Progressive Resistance Training With Breast Cancer Patients During Adjuvant Radiotherapy (BEST)

Breast Cancer | Cancer-related Fatigue

Germany
Novartis Pharmaceuticals
Roche - Prof. Dr. Jens Huober et al.

Terminated

Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer (eLEcTRA)

Metastatic Breast Cancer

Germany
Bristol-Myers Squibb

Completed

Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types

Soft Tissue Sarcoma | Transitional Cell Carcinoma | Advanced Non-small Cell Lung Cancer | Gastric/Esophageal Adenocarcinoma | Pancreatic Cancer Including Ampulla of Vater

United States, Argentina, Germany, Belgium, Canada, Poland, Netherlands, United Kingdom, France
Jazz Pharmaceuticals
BeiGene, Ltd.

Recruiting

A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers (HERIZON-GEA-01)

Gastroesophageal Adenocarcinoma | Esophageal Adenocarcinoma | Gastric Neoplasms

Korea, Republic of, Belgium, Japan, China, Netherlands, Spain, Germany, United Kingdom, Malaysia, Portugal, France, Italy, Australia, Taiwan, Turkey, Thailand, Argentina, Mexico, Ireland, Estonia, Serbia, Romania, Canada, Poland, Brazil, ... and more
University of Giessen

Completed

FEES to Determine Neurological Intensive Care Patients' Oral Diet

Deglutition Disorders | Dysphagia | Aspiration Pneumonia | Intensive Care Neurological Disorder

Germany
Heidelberg University

Unknown

The ARTERY FIRST Approach for Resection of Pancreatic Head Cancer (Artery first)

Pancreatic Head Cancer

Germany
BeiGene

Completed

A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma (ESCC)

Spain, United States, United Kingdom, China, Taiwan, Korea, Republic of, Japan, France, Germany, Belgium, Italy
West German Study Group
Celgene

Active, not recruiting

Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast Cancer (ADAPT)

Breast Cancer

Germany
Ferring Pharmaceuticals

Completed

Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists. (ProComD)

Advanced Prostate Cancer

Germany
University Hospital Tuebingen
University Hospital Freiburg; University Hospital Ulm

Recruiting

Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies

Cervical Cancer | Ovarian Cancer | Vulvar Cancer | Endometrial Cancer | Gynecological Malignancies

Germany
Charite University, Berlin, Germany
Klinikum rechts der Isar, TU München, (TUM), Munich, Germany.

Recruiting

Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells (HSP70CTC)

Sarcoma | Prostate Cancer | Pancreatic Cancer Stage IV | Breast Cancer Stage IV | Squamous Cell Carcinoma | Melanoma Stage IV

Germany
Universität Duisburg-Essen
University Hospital, Essen; Helios Hospital Krefeld; Oslo Centre for Biostatistics...

Recruiting

Cardiorespiratory Fitness in Children and Adolescents After Cancer Treatment. (POWER)

All Types of Pediatric Cancer

Germany
Ludwig-Maximilians - University of Munich
Amgen; ClinAssess GmbH

Not yet recruiting

Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation

Treatment Related Cancer

Germany
AIO-Studien-gGmbH
Merck Sharp & Dohme LLC

Terminated

Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC) (PRIMUS)

Metastatic Squamous Non-small Cell Lung Cancer

Germany
Hoffmann-La Roche

Completed

An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer (GERTAC)

Non-Squamous Non-Small Cell Lung Cancer

Germany
Gesellschaft fur Medizinische Innovation - Hamatologie...
iOMEDICO AG

Completed

Breast Cancer Study: Paclitaxel Versus Paclitaxel Plus Sorafenib in Second- or Third-line Treatment (PASO)

Metastatic Breast Cancer

Germany
Hannover Medical School
Universitätsklinikum Leipzig; UniversitätsKrebsCentrum Dresden

Recruiting

Optimized Psycho-oncological Care Through an Interdisciplinary Care Algorithm (OptiScreen)

Screening | Psycho-Oncology | Visceral Cancer | Psychosocial Stressor

Germany
German Cancer Research Center
University of Leipzig; Heidelberg University; University Hospital Heidelberg; Children...

Completed

Exercise in Pediatric Cancer Patient Undergoing Anti-Cancer Treatment (ONKOKIDS-HD)

Childhood Cancer

Germany
German Breast Group
Pfizer

Completed

Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients (MALE)

Male Breast Cancer

Germany
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., Japan

Completed

Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy

Non-small Cell Lung Cancer

Germany
Universitätsklinikum Hamburg-Eppendorf
Boehringer Ingelheim

Terminated

BIBW 2992 (Afatinib) for the Treatment of Patients With HER2-positive, Hormone-refractory Prostate Cancer

Refractory Cancer

Germany
Philipps University Marburg Medical Center
Universitätsklinikum Hamburg-Eppendorf; University of Hamburg-Eppendorf

Unknown

Side Effect Prevention Training (SEPT) for Nocebo Effects in Breast Cancer Patients

Female Breast Cancer

Germany
RWTH Aachen University

Recruiting

mULM to Support Breast Cancer Diagnosis and Therapy

Primary Breast Cancer

Germany
University Hospital Heidelberg
German Cancer Research Center; Heidelberg University

Active, not recruiting

Tumor-specific T Cells in Lung Cancer

Non-small Cell Lung Cancer

Germany
University Hospital Heidelberg
German Cancer Research Center; Heidelberg University

Completed

Immune Boost In Non-Small Cell Lung Cancer (RadImmune)

Non-small Cell Lung Cancer

Germany
Technische Universität Dresden

Completed

Imaging Methods for the Diagnosis of Non-melanoma Skin Cancer and Its Precursors

Non-melanoma Skin Cancer

Germany
Institut für Klinische Krebsforschung IKF GmbH...
Trium Analysis Online GmbH

Completed

FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer (PETRARCA)

Stomach Cancer | Gastroesophageal Junction Cancer

Germany

Clinical Trials on Esophageal Cancer in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations